Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001209191-22-008981)

Filing Details

Accession Number:: 0001209191-22-008981
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2022-02-11 18:09:14
Reporting Period:: 2022-02-09

Accepted Time:: 2022-02-11 18:09:14
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1595893	Turning Point Therapeutics Inc.	TPTX	()	4

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1341011	Annette North	10628 Science Center Drive San Diego CA 92121	Evp & General Counsel	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2022-02-09	669	$36.30	11,696	No	4	S	Direct
Common Stock	Acquisiton	2022-02-09	16,283	$0.00	27,979	No	4	A	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Direct
No	4	A	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Option (right to buy)	Acquisiton	2022-02-09	58,600	$0.00	58,600	$37.68

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
58,600		2032-02-08	No	4	A	Direct

Footnotes

Sale of shares of common stock to cover tax withholding obligations associated with the vesting of a restricted stock unit award granted to Reporting Person on February 8, 2021.
Represents restricted stock unit award granted under the Issuer's 2019 Equity Plan.
1/48th of the shares vest monthly following February 9, 2022.